The Latest Breaking News from EBS

If so, you’ve got company – nearly one in six Britons have prepared bacon and eggs on an open flame. But not everyone is happy about the practice

The FDA approved a supplemental application to expand Emergent BioSolutions' existing smallpox vaccine to include Mpox.

The White House unveiled the first phase of its national monkeypox vaccine strategy, with plans to send doses to areas with confirmed outbreaks.  The U.S. Department of Health and Human Services plans to distribute 296,000 doses of the Bavarian Nordic A/S's (OTC:BVNRY) Jynneos vaccine, an already-developed monkeypox vaccine. The U.S. is releasing 56,000 doses of…

Emergent BioSolutions Inc (NYSE: EBS) said Johnson & Johnson (NYSE: JNJ) had breached an agreement by failing to buy the company's minimum quantity of COVID-19 vaccines.

By David Bautz, PhD NASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT

According to a recent report from the US House select subcommittee on the coronavirus crisis, Emergent Biosolutions Inc (NYSE:EBS) might have destroyed nearly 400 million doses of COVID-19 vaccines after failing to meet quality standards. Initially, 75 million - 85 million doses of drug substance were said to be destroyed after contamination.  "Despite major…

Emergent BioSolutions Inc (NYSE:EBS) reported Q1 sales of $307.5 million, down 10% Y/Y, beating the consensus of $283 million. Total product sales increased 72% to $237.1 million, while Contract development & manufacturing (CDMO) revenues declined 67% to $60.8 million. The decrease is primarily due to the company's decision to initiate maintenance and…

Russia's rouble tumbled to a fresh record low in thin offshore trade with local markets closed for trading until at least Wednesday. The rouble weakened to 130.9338 to the dollar after closing at 121.037 on Friday, according to Refinitiv data. On the EBS trading platform, the rouble softened to as…

Do the math, and you might wonder if this company’s long-term annual return to investors can beat a Treasury bond’s.